CBAT(CBAT)
CBAT
No analyst ratings available
No analyst price targets available for CBAT
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E |
|---|---|---|
| Revenue Avg | $348M | $463M |
| Low | $348M | $463M |
| High | $348M | $463M |
| EBITDA Avg | $1M | $2M |
| Low | $1M | $2M |
| High | $1M | $2M |
| EBIT Avg | $-17M | $-23M |
| Low | $-17M | $-23M |
| High | $-17M | $-23M |
| Net Income Avg | $-10M | $21M |
| Low | $-10M | $21M |
| High | $-10M | $21M |
| EPS Avg | $-0.11 | $0.24 |
| Low | $-0.11 | $0.24 |
| High | $-0.11 | $0.24 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $95M | $109M | $106M | $114M | $119M | $124M |
| Low | $95M | $109M | $106M | $114M | $119M | $124M |
| High | $95M | $109M | $106M | $114M | $119M | $124M |
| EBITDA Avg | $311,552 | $359,874 | $348,140 | $374,877 | $393,781 | $408,269 |
| Low | $311,552 | $359,874 | $348,140 | $374,877 | $393,781 | $408,269 |
| High | $311,552 | $359,874 | $348,140 | $374,877 | $393,781 | $408,269 |
| EBIT Avg | $-5M | $-5M | $-5M | $-6M | $-6M | $-6M |
| Low | $-5M | $-5M | $-5M | $-6M | $-6M | $-6M |
| High | $-5M | $-5M | $-5M | $-6M | $-6M | $-6M |
| Net Income Avg | $3M | $4M | $3M | $5M | $6M | $7M |
| Low | $3M | $4M | $3M | $5M | $6M | $7M |
| High | $3M | $4M | $3M | $5M | $6M | $7M |
| EPS Avg | $0.03 | $0.04 | $0.03 | $0.06 | $0.07 | $0.08 |
| Low | $0.03 | $0.04 | $0.03 | $0.06 | $0.07 | $0.08 |
| High | $0.03 | $0.04 | $0.03 | $0.06 | $0.07 | $0.08 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |